FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220681907> ?p ?o ?g. }

• W4220681907 endingPage "02" @default.
• W4220681907 startingPage "OT2" @default.
• W4220681907 abstract "Abstract Background Currently, mammographic-based breast cancer screening (BCS) using age as the single criterion for population selection, apart from rare high-risk indications, is being questioned for its imperfect sensitivity (interval cancers) and specificity (false positive recalls), as well as the risk of over-diagnoses. BC risk scores incorporating personal and family history, breast mammographic density and genetic information based on a polygenic score (PRS) give a promisingly accurate likelihood of a woman developing invasive BC in the next 5 years. MyPeBS, a European Commission H2020-funded randomized clinical trial (NCT03672331) conducted in 6 countries (Belgium, France, Israel, Italy, Spain and UK) aims to demonstrate the usefulness of a risk-based screening approach to improve BCS in the general population. Methods MyPeBS’s primary objective is to show non-inferiority of the risk-stratified BCS arm in terms of incidence rate of breast cancer of stage 2 and higher, compared to the standard BCS arm. The key secondary objective, if non-inferiority is shown, is to demonstrate superiority of the risk-based screening arm. MyPeBS also assesses whether this strategy allows reduces morbidity (less false positives); is equally or more cost-effective, and impacts women’s understanding, awareness and emotional responses as compared to standard of care. Women aged 40 to 70 are eligible if they did not have prior BC or high risk-condition, and live in a participating country and area. Participants are randomized 1:1 between standard BCS according to country’s/region’s ongoing policy, or risk-stratified BCS, where screening frequency and method depend on their individual 5 year predicted risk of invasive BC (Table 1). Stratification factors include age, prior mammogram and country. Risk assessment uses a centralized genotyping on a saliva sample to assess PRS 313 (Mavaddat et al, Am J Hum Genet 2019), which is embedded in either a BCSC-derived score for women with at most one first-degree relative with BC; or Tyrer-Cuzick score for women with &gt; 1 family member with breast cancer. Women participate for 4 years. Planned accrual is 85000. On June 30th, 2021, 13882 women have been randomized. Table 1.BC Screening schedule in MyPeBS’ Risk-based armRisk levelLow riskAverage riskHigh riskVery high riskNumerical definition (invasive breast cancer risk at 5 years)&lt;1%1-1.66%≥ 1.66% and &lt; 6%≥ 6%Mammogram1 at end of study (4 years)Every 2 yearsYearlyYearlyAdditionalYearly breast cancer awareness reminderHigh density: US or ABUS every 2 yearsHigh density: US or ABUS every 2 yearsAnnual MRI until age 60 Citation Format: Suzette Delaloge, Paolo Giorgi Rossi, Michal Guindy, Fiona Gilbert, Jean-Benoit Burrion, Corinne Balleyguier, Marta Roman Exposito, Livia Giordano, Harry De Koning, Sandrine de Montgolfier, Stephane Ragusa, Damien Drubay, Marie-Eve Rouge-Bugat, Gareth D Evans, Debbie Keatley, Helene Blanche, Anne Boland, Emilien Gauthier, Aloys Dubois d'Aische, Cécile Vissac-Sabatier, Daniel Couch, Camille Baron, Jean-François Deleuze, Paul Pharoah, Stefan Michiels. Mypebs: An international randomized study comparing personalized, risk-stratified to standard breast cancer screening in women aged 40-70 [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr OT2-10-02." @default.
• W4220681907 created "2022-04-03" @default.
• W4220681907 creator A5005754439 @default.
• W4220681907 creator A5006100928 @default.
• W4220681907 creator A5007383834 @default.
• W4220681907 creator A5009481910 @default.
• W4220681907 creator A5010518270 @default.
• W4220681907 creator A5011031207 @default.
• W4220681907 creator A5017347889 @default.
• W4220681907 creator A5018514656 @default.
• W4220681907 creator A5022371820 @default.
• W4220681907 creator A5029741236 @default.
• W4220681907 creator A5030951678 @default.
• W4220681907 creator A5035759758 @default.
• W4220681907 creator A5036339533 @default.
• W4220681907 creator A5044349222 @default.
• W4220681907 creator A5049107218 @default.
• W4220681907 creator A5050257455 @default.
• W4220681907 creator A5050333038 @default.
• W4220681907 creator A5062814767 @default.
• W4220681907 creator A5063839883 @default.
• W4220681907 creator A5065730986 @default.
• W4220681907 creator A5069451814 @default.
• W4220681907 creator A5072422692 @default.
• W4220681907 creator A5078025092 @default.
• W4220681907 creator A5082334341 @default.
• W4220681907 creator A5083142899 @default.
• W4220681907 date "2022-02-15" @default.
• W4220681907 modified "2023-10-06" @default.
• W4220681907 title "Abstract OT2-10-02: Mypebs: An international randomized study comparing personalized, risk-stratified to standard breast cancer screening in women aged 40-70" @default.
• W4220681907 doi "https://doi.org/10.1158/1538-7445.sabcs21-ot2-10-02" @default.
• W4220681907 hasPublicationYear "2022" @default.
• W4220681907 type Work @default.
• W4220681907 citedByCount "1" @default.
• W4220681907 countsByYear W42206819072022 @default.
• W4220681907 crossrefType "journal-article" @default.
• W4220681907 hasAuthorship W4220681907A5005754439 @default.
• W4220681907 hasAuthorship W4220681907A5006100928 @default.
• W4220681907 hasAuthorship W4220681907A5007383834 @default.
• W4220681907 hasAuthorship W4220681907A5009481910 @default.
• W4220681907 hasAuthorship W4220681907A5010518270 @default.
• W4220681907 hasAuthorship W4220681907A5011031207 @default.
• W4220681907 hasAuthorship W4220681907A5017347889 @default.
• W4220681907 hasAuthorship W4220681907A5018514656 @default.
• W4220681907 hasAuthorship W4220681907A5022371820 @default.
• W4220681907 hasAuthorship W4220681907A5029741236 @default.
• W4220681907 hasAuthorship W4220681907A5030951678 @default.
• W4220681907 hasAuthorship W4220681907A5035759758 @default.
• W4220681907 hasAuthorship W4220681907A5036339533 @default.
• W4220681907 hasAuthorship W4220681907A5044349222 @default.
• W4220681907 hasAuthorship W4220681907A5049107218 @default.
• W4220681907 hasAuthorship W4220681907A5050257455 @default.
• W4220681907 hasAuthorship W4220681907A5050333038 @default.
• W4220681907 hasAuthorship W4220681907A5062814767 @default.
• W4220681907 hasAuthorship W4220681907A5063839883 @default.
• W4220681907 hasAuthorship W4220681907A5065730986 @default.
• W4220681907 hasAuthorship W4220681907A5069451814 @default.
• W4220681907 hasAuthorship W4220681907A5072422692 @default.
• W4220681907 hasAuthorship W4220681907A5078025092 @default.
• W4220681907 hasAuthorship W4220681907A5082334341 @default.
• W4220681907 hasAuthorship W4220681907A5083142899 @default.
• W4220681907 hasConcept C121608353 @default.
• W4220681907 hasConcept C126322002 @default.
• W4220681907 hasConcept C144024400 @default.
• W4220681907 hasConcept C149923435 @default.
• W4220681907 hasConcept C168563851 @default.
• W4220681907 hasConcept C2778491387 @default.
• W4220681907 hasConcept C2780472235 @default.
• W4220681907 hasConcept C2908647359 @default.
• W4220681907 hasConcept C29456083 @default.
• W4220681907 hasConcept C512399662 @default.
• W4220681907 hasConcept C530470458 @default.
• W4220681907 hasConcept C71924100 @default.
• W4220681907 hasConcept C99454951 @default.
• W4220681907 hasConceptScore W4220681907C121608353 @default.
• W4220681907 hasConceptScore W4220681907C126322002 @default.
• W4220681907 hasConceptScore W4220681907C144024400 @default.
• W4220681907 hasConceptScore W4220681907C149923435 @default.
• W4220681907 hasConceptScore W4220681907C168563851 @default.
• W4220681907 hasConceptScore W4220681907C2778491387 @default.
• W4220681907 hasConceptScore W4220681907C2780472235 @default.
• W4220681907 hasConceptScore W4220681907C2908647359 @default.
• W4220681907 hasConceptScore W4220681907C29456083 @default.
• W4220681907 hasConceptScore W4220681907C512399662 @default.
• W4220681907 hasConceptScore W4220681907C530470458 @default.
• W4220681907 hasConceptScore W4220681907C71924100 @default.
• W4220681907 hasConceptScore W4220681907C99454951 @default.
• W4220681907 hasIssue "4_Supplement" @default.
• W4220681907 hasLocation W42206819071 @default.
• W4220681907 hasOpenAccess W4220681907 @default.
• W4220681907 hasPrimaryLocation W42206819071 @default.
• W4220681907 hasRelatedWork W1971803455 @default.
• W4220681907 hasRelatedWork W2041820331 @default.
• W4220681907 hasRelatedWork W2054351563 @default.
• W4220681907 hasRelatedWork W2120803900 @default.
• W4220681907 hasRelatedWork W2529896721 @default.
• W4220681907 hasRelatedWork W2549777276 @default.
• W4220681907 hasRelatedWork W2715581621 @default.

• next